505 related articles for article (PubMed ID: 10585260)
1. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
Balasubramanian S; Chandraratna RA; Eckert RL
Carcinogenesis; 2004 Aug; 25(8):1377-85. PubMed ID: 14976133
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
4. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
5. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
6. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
7. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.
Chattopadhyay N; Butters RR; Brown EM
Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164
[TBL] [Abstract][Full Text] [Related]
8. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist.
Gendimenico GJ; Stim TB; Corbo M; Janssen B; Mezick JA
J Invest Dermatol; 1994 May; 102(5):676-80. PubMed ID: 8176247
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids.
Hellemans K; Verbuyst P; Quartier E; Schuit F; Rombouts K; Chandraratna RA; Schuppan D; Geerts A
Hepatology; 2004 Jan; 39(1):97-108. PubMed ID: 14752828
[TBL] [Abstract][Full Text] [Related]
10. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
11. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
Roy B; Taneja R; Chambon P
Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
[TBL] [Abstract][Full Text] [Related]
14. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
Yokota Y; Ohkubo H
Exp Cell Res; 1996 Oct; 228(1):1-7. PubMed ID: 8892963
[TBL] [Abstract][Full Text] [Related]
15. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
Malashicheva AB; Kisliakova TV; Pospelov VA
Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
[TBL] [Abstract][Full Text] [Related]
16. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
18. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
19. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.
Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P
EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943
[TBL] [Abstract][Full Text] [Related]
20. Receptor-selective retinoids implicate retinoic acid receptor alpha and gamma in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells.
Rogers MB
Cell Growth Differ; 1996 Jan; 7(1):115-22. PubMed ID: 8788040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
